The latest Fairfield Market Research study indicates that the dry eye disease treatment devices market size will inflate at a considerable CAGR of 6% during the period of forecast, 2022-2030. By the end of forecast year, the market revenue will reach US$327.1 Mn.
Market Analysis in Brief
Dry eye disease is a well-known eye condition that mainly involves the inability to sufficiently lubricate eyes and a majority of the affected patients tend to carry chronic inflammation of conjunctiva, and tear glands. While ageing has been the primary factor bolstering demand for dry eye disease treatment, and related devices, the report points to excessive time spent on digital screens as a rapidly emerging factor for the same. A healthy growth outlook has been slated for the dry eye disease treatment devices market. The report has thrown light on the most significant areas of the market to reveal the noteworthy business opportunities, and industry trends for the potential players in this space. The study highlights a continuing opportunity that comes with the consistent innovations in dry eye disease treatment technology.
Key Report Findings
- The global market for dry eye disease treatment devices will reach US$327.1 Mn by 2030-end
- The dry eye disease treatment devices market revenue is poised to see 6% growth in valuation by the end of forecast year
- Meibomian gland unclogging devices continue to be the top selling category
- Wearables show strong indications to develop the highest growth potential
- Ageing, and prolonged screentime will continue to be the largest growth drivers for the market
- Speciality clinics, and eye care centres will register remarkable adoption rates
- North America’s dry eye disease treatment devices market leads, fastest growth expected in Asia Pacific
Growth Drivers
Rise in Geriatric Population, Excessive Screentime, and Growing Chronic Disease Prevalence
The dryness of the cornea increases as the functioning of the meibomian gland gets impacted with increasing age. Approximately 5–30% of the general elderly population suffers from dry eye symptoms. As per the study by the NCBI, the prevalence of dry eye ranges from 8.4% in subjects younger than 60 years old to 15% in patients 70–79 years old, and 20% in those older than 80 years.
Moreover, a notably rising rate of the prevalence of various chronic conditions like diabetes is fuelling the prevalence of dry eye disease condition. This is because the high blood glucose level cause nerve damage in the eyes, which in turn, may lead to dry eyes. Dry eye is seen in both type 1 and type 2 diabetes patients. For example, the rise in the prevalence of diabetes in the US. has been one of the prominent reasons for the increase in dry eye patients in the country.
Government-driven Sophistication of Healthcare Infrastructure
The global dry eye disease treatment devices market leverages lucrative growth opportunities especially in emerging countries viz., China, India, Thailand, Indonesia, and Japan among others. This is attributable to the presence of a huge population base, increasing penetration of the internet and smart gadgets, and the rising number of LASIK and Cataract surgeries in the region.
Asia Pacific’s healthcare infrastructure, especially in the southeast Asian region, is improving owing to the help and support received from the local governments. Such infrastructural development is likely to offer new opportunities for market expansion in emerging Asian countries. Under the Thailand 4.0 policy, the government launched various healthcare applications such as H4U (personal health profile app), Smart Health ID (patient administration cloud service), and Primary Care Cluster App (Telehealth and Telemedicine) during 2018–2020.
The medical tourism industry in Thailand is the fourth largest out of 118 countries across the globe, with most people visiting Bangkok for medical treatment every year. The increasing footfall of medical tourists will drive the demand for quality healthcare services, medical devices, and technology to a significant extent.
Overview of Key Segments
Meibomian Gland Unclogging Devices Segment Leads, Wearable Devices Expect a Higher Growth Rate
Meibomian gland occlusion is a major cause of dry eye disease occurrence. The unclogging devices help to remove the clogged oily material from the meibomian gland supporting the normal functioning of tear production. The dry eye disease treatment devices market is driven by the high demand and utilisation by optometrists, the presence of leading medical device brands offering various categories of meibomian gland unclogging devices viz., LipiFlow Thermal Pulsation System by Johnson & Johnson Vision, and TearCare by Sight Sciences among others.
On the other hand, the wearable devices segment is poised to expand at a high growth rate during the forecast period. The introduction of contact lenses to treat corneal dryness, and the ease of use of these devices are making the segment attractive and driving demand for wearables in the dry eye disease treatment devices market.
Ageing Remains the Largest Cause of Dry Eye Condition
Ageing segment held the highest share of the dry eye disease treatment devices market in terms of cause. People aged more than 65 years typically experience most of the symptoms of dry eye condition. Epidemiological studies conducted by the Women's Health Study and Physician's Health have reported increased dry eye prevalence in women, as well as men at intervals of five years after the age of 50 years. The rate of prevalence is however higher in women than in men.
The ageing segment is expected to dominate throughout the forecast period attributable to the elderly population across the world. The WHO estimates 1 in 6 people will be at or over 60 years of age by 2030. The deepening Internet penetration, and an ever-expanding smartphone userbase have been responsible for the multi-fold rise in the average screentime. This will be an important growth engine for the dry eye disease treatment devices market by the end of 2030.
The Evaporative Application Segment Remains the Largest Revenue Contributor
Evaporation of the tear occurs due to deficient tear film formation. This is caused by meibomian gland dysfunctioning (MGD), a major reason for dry eye disease occurrence. The market is flooded with many MGD treatment devices holding a major chunk of revenue. This segment of the dry eye disease treatment devices market is expected to continue its dominance throughout the forecast period expanding at a high growth rate by the end of 2030.
Eye Care Centres, and Speciality Clinics Account for a Larger Market Share
In terms of end user, the hospital segment held a major market share owing to the high preference given by the patients. The hospitals are equipped with skilled resources and advanced equipment which drives the patient preference.
On the other hand, there are specialty eye care centres emerging across countries offering personalized and advanced treatment modalities for dry eye cases. Cleanliness, special attention, ease of appointments, and relaxed treatment experience are propelling the growth of these segments of the dry eye disease treatment devices market.
Growth Opportunities Across Regions
Sales in North America Maximum
North American region contributed with the highest market share across the globe. Maximum devices are first approved and introduced by the US FDA. These devices are gaining traction as the number of dry eye cases is increasing in the region. The growing geriatric population base, increasing number of smartphone and other digital screen users, and high prevalence of diabetes in the country are certain factors boosting the incidence of dry eye among the American population.
In the US alone, currently, 16 to 49 Mn people suffer from dry eye disease. Based on the data from the National Health and Wellness Survey, 6.8% of the US adult population (approximately 16.4 Mn people) have been diagnosed with dry eye disease.
Asia Pacific Develops a High-potential Market
The Asia Pacific region is expected to drive huge growth in the global dry eye disease treatment devices market during the forecast period. The segment is projected to witness the highest CAGR of 7.8% over the period of forecast. As per the findings reported by the National Institute of Health, the dry eye disease prevalence in India is higher than the global prevalence, i.e., between 18.4% and 54.3%.
Moreover, the concept of dry eye spa is penetrating rapidly in Asian countries like Thailand, Singapore, and Malaysia where there is a large demand for medical tourism. The disease is now treated well in dry eye spas where the use of various laser-based devices and other meibomian gland unclogging devices are used in a relaxing environment. This is attracting a huge patient population to avail themselves of advanced therapies.
Competition Landscape Analysis – Dry Eye Disease Treatment Devices Market
The dry eye disease treatment devices market is moderately consolidated with few players holding considerably high revenue share. Some of the leading companies operating in this market include Alcon Vision LLC, Johnson and Johnson Services Inc., Lumenis Be Ltd, AbbVie Inc., ESW – Vision, Sight Sciences, Eyedetec Medical Inc., BlephEx, MiBo Medical Group, and NuSight Medicals- NuLids LLC.
In April 2022, Alcon LLC, a global leader in the dry eye care treatment devices market, launched the Systane® iLux2® Meibomian Gland Dysfunction (MGD) Thermal Pulsation System.
The Global Dry Eye Disease Treatment Devices Market is Segmented as Below:
By Type
- Meibomian Gland Unclogging Devices
- Wearable Devices
- Punctual Occlusion
- Pain-Reliving Devices
- Others
By Cause
- Idiopathic
- Rare Diseases
- Surgery
- Drug Intake Associated
- Digital Exposure
- Age-Related
By Application
- Aqueous Deficient
- Evaporative
- By End Users
- Hospitals
- Specialty Clinics
- Eye Care Centers
- Others
By Region Coverage
- North America
- United States
- Canada
- Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Indonesia
- Singapore
- Thailand
- Malaysia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Leading Companies
- Alcon Vision LLC
- Johnson and Johnson Services Inc
- AbbVie Inc.
- Lumenis Be Ltd
- ESW – Vision
- MiBo Medical Group
- Sight Sciences
- Eyedetec Medical Inc.
- BlephEx
- NuSight Medicals- NuLids LLC
- Others
Inside This Report You Will Find:
1. Executive Summary
2. Market Overview
3. Global Dry Eye Disease Treatment Devices Market Outlook, 2018 -2030
4. North America Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
5. Europe Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
6. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
7. Latin America Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
8. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
9. Appendix
1. Executive Summary
1.1. Global Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030 (US$ Million)
1.2. Key Industry Trends
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Market Drivers
2.2.2. Market Threats
2.2.3. Market Opportunities
2.3. Regulatory Framework
2.4. Reimbursement Scenario
2.5. LASIK and CATARACT Surgery Statistics, By Key Countries
2.6. Digital Screen Usage Statistics, By Key Countries
3. Global Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
3.1. Global Dry Eye Disease Treatment Devices Market Outlook, By Product Type, 2018 - 2030
3.1.1. Key Highlights
3.1.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
3.1.2.1. Meibomian Gland Unclogging Devices
3.1.2.2. Wearable Devices
3.1.2.3. Punctual Occlusion Devices
3.1.2.4. Pain Relieving Devices
3.1.2.5. Others
3.2. Global Dry Eye Disease Treatment Devices Market Outlook, By Cause, 2018 - 2030
3.2.1. Key Highlights
3.2.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
3.2.2.1. Idiopathic
3.2.2.2. Rare Diseases
3.2.2.3. Surgery
3.2.2.4. Drug Intake Associated
3.2.2.5. Digital Exposure
3.2.2.6. Age Related
3.3. Global Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
3.3.1. Key Highlights
3.3.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
3.3.2.1. Aqueous Deficient
3.3.2.2. Evaporative
3.4. Global Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
3.4.1. Key Highlights
3.4.2. Global Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
3.4.2.1. Hospitals
3.4.2.2. Clinics
3.4.2.3. Eye Care Centres
3.4.2.4. Others
3.5. Global Dry Eye Disease Treatment Devices Market Outlook, By Region, 2018 - 2030
3.5.1. Key Highlights
3.5.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Region, Value (US$ Million), 2018 - 2030
3.5.2.1. North America
3.5.2.2. Europe
3.5.2.3. Asia Pacific
3.5.2.4. Latin America
3.5.2.5. Middle East and Africa
4. North America Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
4.1. North America Dry Eye Disease Treatment Devices Market Outlook, By Country, 2018 - 2030
4.1.1. Key Highlights
4.1.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Million), 2018 - 2030
4.1.2.1. U.S.
4.1.2.2. Canada
4.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Product Type, 2018 - 2030
4.2.1. Key Highlights
4.2.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
4.2.2.1. Meibomian Gland Unclogging Devices
4.2.2.2. Wearable Devices
4.2.2.3. Punctual Occlusion Devices
4.2.2.4. Pain Relieving Devices
4.2.2.5. Others
4.3. North America Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2018 - 2030
4.3.1. Key Highlights
4.3.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
4.3.2.1. Idiopathic
4.3.2.2. Rare Diseases
4.3.2.3. Surgery
4.3.2.4. Drug Intake Associated
4.3.2.5. Digital Exposure
4.3.2.6. Age Related
4.4. North America Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
4.4.1. Key Highlights
4.4.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
4.4.2.1. Aqueous Deficient
4.4.2.2. Evaporative
4.5. North America Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
4.5.1. Key Highlights
4.5.2. North America Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
4.5.2.1. Hospitals
4.5.2.2. Clinics
4.5.2.3. Eye Care Centres
4.5.2.4. Others
5. Europe Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
5.1. Europe Dry Eye Disease Treatment Devices Market Outlook, By Country, 2018 - 2030
5.1.1. Key Highlights
5.1.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Million), 2018 - 2030
5.1.2.1. U.K.
5.1.2.2. France
5.1.2.3. Germany
5.1.2.4. Italy
5.1.2.5. Spain
5.1.2.6. Rest of Europe
5.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Product Type, 2018 - 2030
5.2.1. Key Highlights
5.2.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
5.2.2.1. Meibomian Gland Unclogging Devices
5.2.2.2. Wearable Devices
5.2.2.3. Punctual Occlusion Devices
5.2.2.4. Pain Relieving Devices
5.2.2.5. Others
5.3. Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2018 - 2030
5.3.1. Key Highlights
5.3.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
5.3.2.1. Idiopathic
5.3.2.2. Rare Diseases
5.3.2.3. Surgery
5.3.2.4. Drug Intake Associated
5.3.2.5. Digital Exposure
5.3.2.6. Age Related
5.4. Europe Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
5.4.1. Key Highlights
5.4.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
5.4.2.1. Aqueous Deficient
5.4.2.2. Evaporative
5.5. Europe Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
5.5.1. Key Highlights
5.5.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
5.5.2.1. Hospitals
5.5.2.2. Clinics
5.5.2.3. Eye Care Centres
5.5.2.4. Others
6. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
6.1. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, By Country, 2018 - 2030
6.1.1. Key Highlights
6.1.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Million), 2018 - 2030
6.1.2.1. China
6.1.2.2. India
6.1.2.3. Japan
6.1.2.4. Indonesia
6.1.2.5. Thailand
6.1.2.6. Malaysia
6.1.2.7. Singapore
6.1.2.8. Rest of Asia Pacific
6.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Product Type, 2018 - 2030
6.2.1. Key Highlights
6.2.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
6.2.2.1. Meibomian Gland Unclogging Devices
6.2.2.2. Wearable Devices
6.2.2.3. Punctual Occlusion Devices
6.2.2.4. Pain Relieving Devices
6.2.2.5. Others
6.3. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2018 - 2030
6.3.1. Key Highlights
6.3.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
6.3.2.1. Idiopathic
6.3.2.2. Rare Diseases
6.3.2.3. Surgery
6.3.2.4. Drug Intake Associated
6.3.2.5. Digital Exposure
6.3.2.6. Age Related
6.4. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
6.4.1. Key Highlights
6.4.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
6.4.2.1. Aqueous Deficient
6.4.2.2. Evaporative
6.5. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
6.5.1. Key Highlights
6.5.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
6.5.2.1. Hospitals
6.5.2.2. Clinics
6.5.2.3. Eye Care Centres
6.5.2.4. Others
7. Latin America Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
7.1. Latin America Dry Eye Disease Treatment Devices Market Outlook, By Country, 2018 - 2030
7.1.1. Key Highlights
7.1.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Million), 2018 - 2030
7.1.2.1. Brazil
7.1.2.2. Mexico
7.1.2.3. Rest of Latin America
7.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Product Type, 2018 - 2030
7.2.1. Key Highlights
7.2.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
7.2.2.1. Meibomian Gland Unclogging Devices
7.2.2.2. Wearable Devices
7.2.2.3. Punctual Occlusion Devices
7.2.2.4. Pain Relieving Devices
7.2.2.5. Others
7.3. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2018 - 2030
7.3.1. Key Highlights
7.3.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
7.3.2.1. Idiopathic
7.3.2.2. Rare Diseases
7.3.2.3. Surgery
7.3.2.4. Drug Intake Associated
7.3.2.5. Digital Exposure
7.3.2.6. Age Related
7.4. Latin America Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
7.4.1. Key Highlights
7.4.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
7.4.2.1. Aqueous Deficient
7.4.2.2. Evaporative
7.5. Latin America Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
7.5.1. Key Highlights
7.5.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
7.5.2.1. Hospitals
7.5.2.2. Clinics
7.5.2.3. Eye Care Centres
7.5.2.4. Others
8. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, 2018 - 2030
8.1. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, By Country, 2018 - 2030
8.1.1. Key Highlights
8.1.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Million), 2018 - 2030
8.1.2.1. GCC
8.1.2.2. South Africa
8.1.2.3. Rest of Middle East and Africa
8.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Product Type, 2018 - 2030
8.2.1. Key Highlights
8.2.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Product Type, Value (US$ Million), 2018 - 2030
8.2.2.1. Meibomian Gland Unclogging Devices
8.2.2.2. Wearable Devices
8.2.2.3. Punctual Occlusion Devices
8.2.2.4. Pain Relieving Devices
8.2.2.5. Others
8.3. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2018 - 2030
8.3.1. Key Highlights
8.3.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Million), 2018 - 2030
8.3.2.1. Idiopathic
8.3.2.2. Rare Diseases
8.3.2.3. Surgery
8.3.2.4. Drug Intake Associated
8.3.2.5. Digital Exposure
8.3.2.6. Age Related
8.4. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, By Application, 2018 - 2030
8.4.1. Key Highlights
8.4.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Million), 2018 - 2030
8.4.2.1. Aqueous Deficient
8.4.2.2. Evaporative
8.5. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, By End User, 2018 - 2030
8.5.1. Key Highlights
8.5.2. Middle East and Africa Dry Eye Disease Treatment Devices Market Outlook, by End User, Value (US$ Million), 2018 - 2030
8.5.2.1. Hospitals
8.5.2.2. Clinics
8.5.2.3. Eye Care Centres
8.5.2.4. Others
8.6. Competitive Landscape
8.6.1. Company Profiles
8.6.1.1. Alcon Vision LLC.
8.6.1.1.1. Company Overview
8.6.1.1.2. Financial Performance
8.6.1.1.3. Product Portfolio
8.6.1.1.4. Pipeline Analysis
Above details will include, but not be limited to below list of companies based on availability
8.6.1.2. Johnson and Johnson Services Inc.
8.6.1.3. AbbVie Inc.
8.6.1.4. Lumenis Be Ltd
8.6.1.5. ESW-Vision
8.6.1.6. Mibo Medical Group
8.6.1.7. Sight Sciences.
8.6.1.8. Eyedetect Medical Inc.
8.6.1.9. BlephEx
8.6.1.10. NuSight Medicals-Nulids LLC
8.6.1.11. Others
9. Appendix
9.1 Research Methodology
9.2 Report Specific Research Approach
|
BASE YEAR |
HISTORICAL DATA |
FORECAST PERIOD |
UNITS |
|||
 |
2021 |
 |
2019 - 2021 |
 |
2022 - 2030 |
Value: US$ Million |
|
REPORT FEATURES |
DETAILS |
|
Type Coverage |
|
|
Cause Coverage |
|
|
Application Coverage |
|
|
End User Coverage |
|
|
Region Coverage |
|
|
Leading Companies |
|
|
Report Highlights |
Key Market Indicators, Macro-micro economic impact analysis, Technological Roadmap, Key Trends, Driver, Restraints, and Future Opportunities & Revenue Pockets, Porter’s 5 Forces Analysis, Historical Trend (2019-2021), Price Trend Analysis, Market Estimates and Forecast, Market Dynamics, Industry Trends, Competition Landscape, Category, Region, Country-wise Trends & Analysis, COVID-19 Impact Analysis (Demand and Supply Chain) |
Quality assured
